Wenlu Li

Nov 29, 2024 | molecular-cancer.biomedcentral.com | Menglei Jin |Jun Fang |Junwen Peng |Xintian Tina Wang |Ping Ping Xing |Kunpeng Jia | +6 more

Tumor-infiltrating lymphocytes (TILs) have emerged as a readily available and effective marker for assessing tumor immune profiles (Fig. 4). The pathological evaluation of TILs offers a convenient approach to identifying patients who are likely to respond favorably to immunotherapy. For instance, a randomized trial found that a TIL level of ≥ 5% could predict a positive response to pembrolizumab.

Aug 21, 2024 | cell.com | Jin Billy Li |Dan Cao |Wenlu Li

Highlights Intracranial neural recordings have revealed the distinct roles of various medial temporal lobe (MTL) regions in working memory (WM). MTL regions exhibit specific interactions both internally and with the neocortex, engaging in distinct oscillatory patterns across various phases of WM. Incorporating the MTL into working memory models deepens our understanding of the intricate neural mechanisms that underlie WM.

Jul 4, 2024 | dovepress.com | Wenlu Li |Jiong Liu |Yaolin Gong

Wenlu Li,1,2,* Yaolin Gong,1,2,* Jing Zhang,1,2 Jiong Liu,1,2 Jiali Li,1,2 Shaozhi Fu,3 Wen Xiu Ren,1,2 Jian Shu1,2 1Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 3Department of Oncology, The Affiliated Hospital of Southwest...

Mar 20, 2023 | nature.com | Wenlu Li

In total, 467 patients were enrolled for analysis (200 men, 267 women; median age 50 [range 20–76]) years. Smoking and drinking were noted in 68 and 35 patients, respectively. The number of previous recurrences was distributed as 0 in 203 patients, 1 in 113 patients, 2 in 78 patients, 3 in 45 patients, and 4 or more in 28 patients. The median duration between initial PA and current recurrence was 7 years with a range from 1 to 24 years. No patients received radiotherapy previously.